Abstract
Megosin is the original derivative of gossypol. Previously, the drug was obtained by condensation of gossypol with β-aminoethylsulfate sodium and used as an immunosuppressive agent, which was a low-toxic substance and contributed to a longer engraftment of skin flaps in mice, kidneys and lungs in dogs. Further, it was used as an antiherpetic agent, in the form of a 3% ointment. At present, the Institute of Bioorganic Chemistry, on the basis of existing dosage forms, has developed megosin enteric capsules for the treatment of ulcerative colitis and conducted histological studies, which proved the ulcer-healing effect of the new dosage form of megosin.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
